AXM Pharma, Inc.
AXMP
$0.00
$0.000.00%
OTC PK
| 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.66M | 1.66M | 2.17M | 2.17M | -- |
| Total Receivables | 5.88M | 5.88M | 6.02M | 6.02M | -- |
| Inventory | 29.93M | 29.93M | 31.64M | 31.64M | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 587.50K | 587.50K | -- | -- | -- |
| Total Current Assets | 38.06M | 38.06M | 39.83M | 39.83M | -- |
|
|
|||||
| Total Current Assets | 38.06M | 38.06M | 39.83M | 39.83M | -- |
| Net Property, Plant & Equipment | 62.93M | 62.93M | 56.97M | 56.97M | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 5.83M | 5.83M | -- |
| Total Assets | 102.41M | 102.41M | 104.43M | 104.43M | -- |
|
|
|||||
| Total Accounts Payable | 11.90M | 11.90M | 19.66M | 19.66M | -- |
| Total Accrued Expenses | 13.00K | 13.00K | 12.00K | 12.00K | -- |
| Short-term Debt | 27.94M | 27.94M | 22.40M | 22.40M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 14.61M | 14.61M | 16.30M | 16.30M | -- |
| Total Other Current Liabilities | 14.61M | 14.61M | 16.30M | 16.30M | -- |
| Total Current Liabilities | 54.45M | 54.45M | 58.36M | 58.36M | -- |
|
|
|||||
| Total Current Liabilities | 54.45M | 54.45M | 58.36M | 58.36M | -- |
| Long-Term Debt | 1.39M | 1.39M | 3.61M | 3.61M | -- |
| Short-term Debt | 27.94M | 27.94M | 22.40M | 22.40M | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 55.85M | 55.85M | 61.97M | 61.97M | -- |
|
|
|||||
| Common Stock & APIC | 8.83M | 8.83M | 8.83M | 8.83M | -- |
| Retained Earnings | 34.90M | 34.90M | 30.86M | 30.86M | -- |
| Treasury Stock & Other | 2.83M | 2.83M | 2.77M | 2.77M | -- |
| Total Common Equity | 46.56M | 46.56M | 42.46M | 42.46M | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 46.56M | 46.56M | 42.46M | 42.46M | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 46.56M | 46.56M | 42.46M | 42.46M | -- |
|
|
|||||